Catalyst Pharmaceuticals was founded in 2002 and is headquartered in Coral Gables, US

Catalyst Pharmaceuticals has an office in Coral Gables

Coral Gables, US (HQ)

1250 355 Alhambra Cir

Catalyst Pharmaceuticals's revenue was reported to be $0 in Q1, 2017

USD

## Net income (Q1, 2017) | (5 m) |

## EBIT (Q1, 2017) | (4.7 m) |

## Market capitalization (22-Aug-2017) | 228.2 m |

## Cash (31-Mar-2017) | 10 m |

Catalyst Pharmaceuticals's current market capitalization is $228.2 m.

- Source: SEC Filings

USD | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|

## R&D expense | 10.1 m | 11.8 m | 11.4 m |

## General and administrative expense | 4.5 m | 8.6 m | 7.9 m |

## Operating expense total | 14.6 m | 20.4 m | 19.3 m |

## EBIT | (14.6 m) | (20.4 m) | (19.3 m) |

## Pre tax profit | (15.5 m) | (20.2 m) | (18.1 m) |

## Net Income | (15.5 m) | (20.2 m) | (18.1 m) |

USD | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|

## R&D expense | 2.6 m | 3 m | 3.5 m | 2.5 m | 2.5 m | 2.8 m |

## General and administrative expense | 2.3 m | 2 m | 2.7 m | 2.3 m | 1.4 m | 1.9 m |

## Operating expense total | 4.9 m | 5 m | 6.2 m | 4.8 m | 3.9 m | 4.7 m |

## EBIT | (4.9 m) | (5 m) | (6.2 m) | (4.8 m) | (3.9 m) | (4.7 m) |

## Pre tax profit | (4.6 m) | (4.4 m) | (5.4 m) | (4.6 m) | (4 m) | (5 m) |

## Net Income | (10 m) | (14.4 m) | (5.4 m) | (10 m) | (13.9 m) | (5 m) |

- Source: SEC Filings

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 2.2 m | 9.1 m | 28.2 m | 13.9 m |

## Inventories | 4.6 m | 1.5 m | 1 m | |

## Current Assets | 25.3 m | 43.8 m | 59.9 m | 41.5 m |

## PP&E | 40.6 k | 71.4 k | 191.5 k | 244.2 k |

## Total Assets | 25.4 m | 43.9 m | 60.1 m | 41.7 m |

## Accounts Payable | 850.8 k | 1.8 m | 1.8 m | 933.2 k |

## Current Liabilities | 2.1 m | 5.9 m | 3.4 m | 2.1 m |

## Total Liabilities | 2.4 m | |||

## Additional Paid-in Capital | 75.7 m | 105 m | 145.5 m | 147.4 m |

## Retained Earnings | (69.8 m) | (90.1 m) | (108.1 m) | |

## Total Equity | 21.4 m | 35.2 m | 55.5 m | 39.3 m |

## Financial Leverage | 1.2 x | 1.2 x | 1.1 x | 1.1 x |

USD | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|

## Cash | 41.3 m | 37.2 m | 32.8 m | 22.2 m | 18.7 m | 17.6 m | 10 m |

## Current Assets | 76 m | 68.3 m | 64.4 m | 53.5 m | 48.7 m | 45.1 m | 37.5 m |

## PP&E | 71.1 k | 63.3 k | 197.6 k | 178.4 k | 258.5 k | 249 k | 231.2 k |

## Total Assets | 76 m | 68.3 m | 64.6 m | 53.7 m | 48.9 m | 45.3 m | 37.7 m |

## Accounts Payable | 1.1 m | 1.3 m | 817 k | 1.3 m | 707.3 k | 1.1 m | 917.9 k |

## Current Liabilities | 5.8 m | 2.6 m | 2.4 m | 2.7 m | 2.3 m | 2 m | 1.9 m |

## Additional Paid-in Capital | 141.8 m | 142.5 m | 144.8 m | 145.9 m | 146.3 m | 146.8 m | 148.1 m |

## Retained Earnings | (75.3 m) | (79.8 m) | (84.3 m) | (95.5 m) | (100 m) | (104 m) | (113.1 m) |

## Total Equity | 66.6 m | 62.8 m | 60.6 m | 50.5 m | 46.3 m | 42.9 m | 35.1 m |

## Financial Leverage | 1.1 x | 1.1 x | 1.1 x | 1.1 x | 1.1 x | 1.1 x | 1.1 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | (12.2 m) | (15.5 m) | (20.2 m) | (18.1 m) |

## Depreciation and Amortization | 22.5 k | 26.6 k | 34.5 k | 43.4 k |

## Accounts Payable | (514.9 k) | 963.4 k | (20.1 k) | (861 k) |

## Cash From Operating Activities | (9.9 m) | (12.9 m) | (18 m) | (18 m) |

## Capital Expenditures | (9.4 k) | (57.3 k) | (23.5 k) | (96.1 k) |

## Cash From Investing Activities | (7.5 m) | (8.7 m) | (6.5 k) | 3.6 m |

## Cash From Financing Activities | 18.2 m | 28.6 m | 37.2 m | 69 k |

## Free Cash Flow | (9.9 m) | (13 m) | (18 m) | (18.1 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|

## Net Income | (10 m) | (14.4 m) | (5.4 m) | (10 m) | (13.9 m) | (5 m) | ||

## Depreciation and Amortization | 17.1 k | 28.4 k | 13.2 k | 22 k | 31.4 k | 13 k | ||

## Accounts Payable | 1.2 m | 524.8 k | (497.9 k) | (997.2 k) | (542.7 k) | (1.1 m) | (738.8 k) | (15.2 k) |

## Cash From Operating Activities | (8 m) | (13.4 m) | (5.9 m) | (10.3 m) | (13.6 m) | (3.9 m) | ||

## Capital Expenditures | (9 k) | (23.5 k) | (7.9 k) | (88.9 k) | (88.9 k) | |||

## Cash From Investing Activities | (12.6 k) | (57 k) | (65.6 k) | 767.1 k | 3 m | (33.1 k) | ||

## Cash From Financing Activities | 36.2 m | 37.1 m | (11.3 k) | (11.3 k) | (11.3 k) | (11.3 k) | ||

## Free Cash Flow | (8 m) | (13.4 m) | (5.9 m) | (10.4 m) | (13.6 m) |

Y, 2017 | |
---|---|

## Financial Leverage | 1.1 x |